Dr. Mou is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 Hawkins Dr
Iowa City, IA 52242Phone+1 319-356-1206
Education & Training
- Stanford Health Care-Sponsored Stanford UniversityFellowship, Hematology and Medical Oncology, 2017 - 2020
- Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 2014 - 2017
- University of Iowa Roy J. and Lucille A. Carver College of MedicineClass of 2014
Certifications & Licensure
- IA State Medical License 2020 - 2026
- CA State Medical License 2015 - 2021
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- The A-HIPI Prediction Model in Advanced Stage Hodgkin Lymphoma: Identification of Risk Groups and Creation of an Online Tool.Matthew J Maurer, Susan K Parsons, Jenica N Upshaw, Angie Mae Rodday, Raphael Mwangi
Blood Advances. 2025-01-08 - 1 citationsOvercoming Tagraxofusp-Erzs Monotherapy Resistance in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) in a Real-World Clinical Setting.Prajwal Dhakal, Mario Sy, Grerk Sutamtewagul, Eric Mou, Nanmeng Yu
Journal of Immunotherapy and Precision Oncology. 2024-08-01 - Clinical characteristics, treatment patterns, and outcomes of cytotoxic cutaneous T-cell lymphomas.Eric Mou, Sebastian Fernandez-Pol, Shufeng Li, Kerri E Rieger, Roberto Novoa
American Journal of Hematology. 2024-05-01
Abstracts/Posters
- Brief Pembrolizumab(PEM) Monotherapy Results in Complete and Near Complete Responses in the Majority of Untreated Patients with Classical Hodgkin Lymphoma (cHL): A Mul...Eric Mou, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Fitness and Anthracycline Use in Front-Line Therapy for Older Patients with Classical Hodgkin Lymphoma: A US Multi-Center Retrospective AnalysisEric Mou, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: